Jack Abraham - Aug 6, 2021 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
10%+ Owner
Signature
/s/ Jack Abraham
Stock symbol
HIMS
Transactions as of
Aug 6, 2021
Transactions value $
$0
Form type
4
Date filed
8/6/2021, 07:19 PM
Next filing
Dec 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +4.01K +0.56% 722K Aug 6, 2021 Direct F1, F2
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +1.56K +0.56% 280K Aug 6, 2021 See Footnote F1, F3
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +7.28K +0.56% 1.31M Aug 6, 2021 See Footnote F1, F4
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +5.44K +0.56% 979K Aug 6, 2021 See Footnote F1, F5
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +45.6K +0.56% 8.2M Aug 6, 2021 See Footnote F1, F6
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +46.2K +0.56% 8.31M Aug 6, 2021 See Footnote F1, F7
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +24.4K +0.56% 4.4M Aug 6, 2021 See Footnote F1, F8
transaction HIMS Class A Common Stock Sale -2.94K -0.41% 719K Aug 6, 2021 Direct F2, F9
transaction HIMS Class A Common Stock Sale -1.14K -0.41% 279K Aug 6, 2021 See Footnote F3, F9
transaction HIMS Class A Common Stock Sale -5.34K -0.41% 1.3M Aug 6, 2021 See Footnote F4, F9
transaction HIMS Class A Common Stock Sale -3.99K -0.41% 975K Aug 6, 2021 See Footnote F5, F9
transaction HIMS Class A Common Stock Sale -33.4K -0.41% 8.17M Aug 6, 2021 See Footnote F6, F9
transaction HIMS Class A Common Stock Sale -33.9K -0.41% 8.28M Aug 6, 2021 See Footnote F7, F9
transaction HIMS Class A Common Stock Sale -17.9K -0.41% 4.38M Aug 6, 2021 See Footnote F8, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -4.01K -100% $0.00* 0 Aug 6, 2021 Class A Common Stock 4.01K Direct F1, F2
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -1.56K -100% $0.00* 0 Aug 6, 2021 Class A Common Stock 1.56K See Footnote F1, F3
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -7.28K -100% $0.00* 0 Aug 6, 2021 Class A Common Stock 7.28K See Footnote F1, F4
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -5.44K -100% $0.00* 0 Aug 6, 2021 Class A Common Stock 5.42K See Footnote F1, F5
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -45.6K -100% $0.00* 0 Aug 6, 2021 Class A Common Stock 45.6K See Footnote F1, F6
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -46.2K -100% $0.00* 0 Aug 6, 2021 Class A Common Stock 46.2K See Footnote F1, F7
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -24.4K -100% $0.00* 0 Aug 6, 2021 Class A Common Stock 24.4K See Footnote F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised.
F2 These securities are owned directly by the Reporting Person. The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities.
F3 Securities are owned by Atomic Incentives, LLC ("Incentives"). Atomic Labs, LLC ("Labs") is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives.
F4 Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I.
F5 Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B.
F6 Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41.
F7 Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II.
F8 Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person.
F9 Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above.